arrow
C

Consuelo Corti

IRCCS San Raffaele Scientific Institute
H指数:23
被引数:2,391

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Empirical Therapy in High-Risk Hematological Patients with Carbapenem-Resistant Enterobacterales Colonization: Real-World Treatment Decisions and Antimicrobial Stewardship Implications

在高风险血液病患者中,对碳青霉烯耐药肠杆菌科细菌定植的的经验性治疗:真实世界治疗决策和抗菌药物合理使用的影响

2026-10-080
OA
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome

免疫效应细胞相关噬血细胞综合征的早期诊断生物标志物

2025-08-140
PRE
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
2024-09-201
OAAI
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies
2024-01-061
OAAI
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients

异基因造血干细胞移植受者的人类疱疹病毒6特异性T细胞免疫

2023-09-1511
OAAI
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft- versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases
2023-08-011
PRE
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience
2023-07-013
PRE
Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: A single center experience
2023-07-012
OAAI
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
2023-05-235
OAAI
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
2023-04-269
OAAI
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation

限制共享和供体人类白细胞抗原的巨细胞病毒特异性T细胞对异基因造血干细胞移植后巨细胞病毒再激活风险的差异影响

2022-10-0610
OAAI
Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
2022-07-282
OAAI
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors

阿扎胞苷和供体淋巴细胞输注在替代供体异基因造血干细胞移植后复发的急性髓系白血病和骨髓增生异常综合征中

2022-06-176
OAAI
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation
2022-05-1710
OAAI
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study
2022-02-1911
OAAI
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial
2021-09-108
OAAI